ApoB vs Lp(a): what each test tells you

The short version

Think of ApoB as a headcount and Lp(a) as a genetic trait. ApoB tells you how many potentially harmful particles are circulating right now. Lp(a) tells you whether you carry an inherited particle that adds risk on top of everything else.

• ApoB: reflects LDL, VLDL and related particles; rises with insulin resistance, central weight and diet; falls with treatment; useful for monitoring.
• Lp(a): an LDL-like particle with an extra protein attached; about 1 in 5 people have high levels; largely unaffected by diet and exercise; generally measured once.
• Both: independent risk markers for heart attack and stroke, and neither shows whether plaque is already present.

Where they overlap

Every atherogenic particle carries one ApoB molecule, including Lp(a) particles. So Lp(a) is technically part of the ApoB count. In most people, though, Lp(a) particles make up a small share of the total, so a normal ApoB does not tell you whether your Lp(a) is high. Lp(a) needs its own test, and the American Heart Association notes that a standard cholesterol panel does not include it.

Where they differ

The biggest practical difference is what you can do with the result. ApoB is a target: it moves with diet, weight loss, exercise, better insulin sensitivity and lipid-lowering medicine, so it makes sense to recheck it after changes. The ACC's summary of the 2026 ACC/AHA dyslipidemia guideline notes that ApoB better reflects risk and that treatment can be intensified when it is elevated even if LDL-C is at goal.

Lp(a) is largely set by your genes. The National Heart, Lung, and Blood Institute notes that it does not fluctuate much with modifiable factors, which is why a one-time measurement is usually enough. Its value lies in how it changes your overall risk estimate and how aggressively other factors should be managed.

Who benefits from each test

ApoB tends to add the most when standard numbers may understate risk.

• Triglycerides are high
• You have insulin resistance, prediabetes or a growing waist
• LDL cholesterol looks fine but family history or other factors are concerning
• You are on lipid-lowering treatment and want a more precise target

Lp(a) testing

Because Lp(a) is common, inherited and invisible on a routine panel, the 2026 ACC/AHA guideline recommends measuring it at least once in every adult's lifetime, and the AHA encourages testing particularly with a personal or family history of premature heart disease or familial hypercholesterolemia. If your level is high, parents, siblings and children may want to be tested too.

The ACC summary notes that levels above 125 nmol/L are associated with about 1.4 times higher risk, and above 250 nmol/L with at least double the risk.

If your Lp(a) is high, does ApoB still matter?

Yes, arguably more. Because you cannot easily lower Lp(a) itself, lowering everything else becomes the main strategy. That means getting ApoB and LDL-C down, controlling blood pressure, not smoking and improving insulin sensitivity. Some lipid-lowering drugs reduce Lp(a) modestly, and Lp(a)-specific medicines are being studied, but none is yet standard practice.

Practical points before testing

Neither test requires fasting, which makes them easy to add to a routine blood draw. Try to avoid testing during an acute illness, and use the same lab if you plan to track ApoB over time, since methods differ. Lp(a) results can be reported in nmol/L or mg/dL; those units are not directly interchangeable, so note which one your lab uses.

If you are already on a statin or other lipid-lowering medicine, tell your clinician, as treatment changes ApoB and can modestly affect Lp(a).

A simple way to remember the difference

ApoB answers the question: how much atherogenic traffic is on the road today? Lp(a) answers a different one: did you inherit a particularly troublesome type of vehicle? Knowing both helps a clinician judge how hard to push on the factors you can change.

What neither test tells you

Both tests describe risk, not disease. Neither shows whether plaque has already formed in your arteries. That requires imaging such as a coronary artery calcium scan, which the 2026 guideline now endorses for refining risk in some people. HealifyMD does not provide imaging, but your clinician can discuss when it would be worth arranging locally.

HealifyMD's Comprehensive Lab Panel is $199, confirmed at your eligibility review, and a licensed clinician can advise whether ApoB, Lp(a) or both make sense for you.